LONDON Toumaz Technology, a U.K. developer of RF, analog and mixed signal semiconductors, has appointed Dr Ian Lindsay McWalter as its new Chief Executive Officer. Keith Errey, who served as Toumaz CEO since co-founding the company in 2000, will take on the role of Chief Operating Officer (COO).
Dr McWalter was most recently President and CEO of Canadian semiconductor manufacturer Gennum Corporation, and brings to his new role over 30 years of experience in the semiconductor and electronics industry – 20 of those gained in senior management positions at Gennum and Nortel. For the past 5 years Dr. McWalter was President and Chief Executive Officer of Gennum and gained a Ph.D in Electrical Engineering from Imperial College in 1976.
Dr McWalter joins Toumaz (Abingdon, England) with a focus on accelerating the commercialization of Toumaz’s proprietary AMx advanced mixed signal technology within its key healthcare and consumer electronic markets.
Following its acquisition in November 2005 by AIM-listed nanotechnology investment vehicle Nanoscience Inc., Toumaz announced plans to invest in a number of key areas, including ongoing development of new products and the ultra-low power Sensium family of devices, investigations into advanced semiconductor processes and the strengthening of the company’s engineering and commercial teams.
Richard Rose, Non-Executive Chairman of Nanoscience, said, “We are extremely pleased with the appointment of Dr. McWalter to the role of CEO at Toumaz Technology. With his wealth of industry experience and strong track record in commercializing semiconductor technology, I believe Dr McWalter is ideally suited to lead Toumaz’s development into a revenue-generating commercial supplier of ultra-low power integrated circuits and silicon chip solutions.”
In July 2005 Bio-Nano Sensium Technologies, a joint venture between Toumaz Technology and Advance Nanotech, developed a board level demonstrator of the Bio-Nano Sensium (BNS) ultra-lower power wireless monitoring system with the potential to revolutionise healthcare management.